FLGR-242 20mg — Vial Spec, Reconstitution Math & COA

Overview of FLGR-242 20mg Lyophilized Format

In laboratory research settings, selecting the correct vial mass is essential for minimizing batch-to-batch variability and optimizing volumetric preparation. The FLGR-242 20mg specification provides a concentrated mass of lyophilized peptide suitable for laboratories running multiple parallel assays, microplate titration series, or extended preclinical model evaluations.

FLGR-242 is synthesized and supplied strictly as a research-grade compound for in vitro and laboratory investigation. While PX1 Research maintains various production lots and packaging formats, researchers should check our complete catalog of all peptides or view the main FLGR-242 catalog entry to confirm current inventory status and active fill sizes. If a specific 20mg fill size is temporarily out of stock or custom-synthesized for bulk institutional orders, standard smaller unit sizes can be combined using identical reconstitution principles.

Reconstitution Math for 20mg Vials

Precise reconstitution of a 20mg lyophilized cake requires calculated volumetric additions of sterile diluent—such as bacteriostatic water or sterile 0.9% sodium chloride—to achieve desired working stock concentrations. Because 20mg represents a relatively large mass per vial, choosing the volume of diluent dictates the resulting mg/mL ratio:

• Reconstitution with 1.0 mL diluent yields a final stock concentration of 20.0 mg/mL (20,000 µg/mL). • Reconstitution with 2.0 mL diluent yields a final stock concentration of 10.0 mg/mL (10,000 µg/mL). • Reconstitution with 3.0 mL diluent yields a final stock concentration of 6.67 mg/mL (6,670 µg/mL). • Reconstitution with 4.0 mL diluent yields a final stock concentration of 5.0 mg/mL (5,000 µg/mL).

To rapidly verify volumetric calculations and volumetric unit conversions across various diluent options, investigators can utilize the PX1 reconstitution calculator. Ensuring accurate working stock math is critical before transferring reconstituted solutions into cell culture media or automated microplate dispenser systems.

Aliquot Planning and Serial Dilutions

Handling high-mass vials like FLGR-242 20mg requires deliberate aliquot planning. Repeated freeze-thaw cycles degrade peptide bond integrity and promote aggregation, which skews binding affinity data in vitro. Once the primary reconstitution is complete, the stock solution should be divided into single-use micro-aliquots using sterile polypropylene low-binding tubes.

For serial dilution protocols, primary stock solutions (e.g., 10 mg/mL) are typically diluted down to nanomolar or micromolar ranges using culture media or phosphate-buffered saline (PBS). Because FLGR-242 exhibits distinct solubility kinetics depending on pH and ionic strength, primary reconstitution in sterile water or bacteriostatic water prior to dilution in buffered media is highly recommended to prevent premature precipitation.

Storage Guidelines and Lyophilized Stability

Unopened, lyophilized FLGR-242 20mg vials must be stored in a dry, dark environment at temperature thresholds between -20°C and -80°C to preserve long-term chemical stability. Under proper desiccated, sub-zero conditions, lyophilized peptide cakes maintain structural integrity for extended research timelines.

Following reconstitution, liquid aliquots stored at 2°C to 8°C should be utilized within 14 to 28 days if prepared with bacteriostatic water containing 0.9% benzyl alcohol. For long-term liquid storage of aliquots without preservatives, solutions must be flash-frozen at -80°C. Repeated temperature fluctuations should be strictly avoided by structuring experiment schedules around individual aliquot usage.

Lot-Matched COA and Analytical Verification

Every production lot of FLGR-242 manufactured for PX1 Research undergoes rigorous third-party analytical verification in an ISO 17025 accredited laboratory. High-Performance Liquid Chromatography (HPLC) is employed to confirm chemical purity (>98%), while Mass Spectrometry (MS) verifies exact molecular weight and amino acid sequence matching.

Additionally, all lots undergo standard Limulus Amebocyte Lysate (LAL) testing to ensure endotoxin limits meet strict laboratory standards for in vitro cellular assays. Researchers can access fully traceable analysis records directly via our online portal for any active or historical lot by visiting our dedicated COA lookup page.

Comparative Analysis: FLGR-242 in Strength & Pathway Research

Within the broader landscape of strength, muscle remodeling, and regulatory pathway research, FLGR-242 is evaluated alongside several other specialized peptide agents. Preclinical literature often compares the binding profiles, receptor affinities, and signaling cascades of these compounds in cell-based assays.

For instance, investigators exploring myostatin-inhibition mechanisms often cross-reference FLGR-242 with research compounds such as follistatin-315 and ace-031. While follistatin derivatives target circulating TGF-beta superfamily ligands directly, FLGR-242 offers distinct structural modifications designed for targeted pathway investigation. Furthermore, when evaluating broader anabolic signal transduction, labs frequently compare these pathways to growth hormone secretagogue models like cjc-1295-no-dac to observe downstream gene expression differences in vitro.

Selecting the Optimal Vial Size: 5mg vs 10mg vs 20mg

Determining whether to order 5mg, 10mg, or 20mg vials depends on the specific scale and duration of the planned research protocol. Smaller vial sizes (e.g., 5mg) are generally preferred for exploratory pilot studies, short-term cell viability assays, or preliminary solubility testing where minimal peptide solution is required.

Conversely, the FLGR-242 20mg format is ideal for high-throughput screening arrays, multi-week preclinical animal models, or shared laboratory facilities where high stock volumes are needed across multiple workstations simultaneously. Utilizing a single 20mg vial reduces inter-vial variance across large experimental cohorts, provided aliquot integrity is preserved.

Laboratory Safety, Handling, and Procurement

FLGR-242 is intended exclusively for qualified laboratory researchers operating in controlled academic, industrial, or clinical research environments. Standard Biosafety Level 1 or 2 (BSL-1/BSL-2) precautions must be maintained during handling, including personal protective equipment (PPE), laminar flow hoods for reconstitution, and sterile handling procedures.

PX1 Research manufactures all compounds in USA-based GMP-compliant facilities to guarantee rigorous quality standards. Principal investigators and procurement officers interested in bulk sourcing, recurring lab supply schedules, or institutional account setups can learn more by visiting our dedicated wholesale portal or exploring our broader research hub.